Skip to main content
Clinical Trials/NCT02617602
NCT02617602
Unknown
Phase 3

Goal Directed Hemodynamic Management of Acute Heart Failure After Cardiac Surgery in Children: a Prospective Randomised Trial

Meshalkin Research Institute of Pathology of Circulation1 site in 1 country40 target enrollmentDecember 2015
ConditionsCardiac Surgery

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Cardiac Surgery
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Enrollment
40
Locations
1
Primary Endpoint
Major complications
Last Updated
10 years ago

Overview

Brief Summary

Goal directed therapy (GDT) utilises various monitoring techniques to assess cardiovascular performance and allows for timely interventions based on predetermined algorithms. The aim of this prospective randomised study is to evaluate the effect of GDT on major complications in children undergoing radical correction of congenital heart defects, complicated by acute heart failure. Goal directed therapy will be implemented with the aid of transpulmonary thermodilution and based on predetermined algorithms.

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
December 2017
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Meshalkin Research Institute of Pathology of Circulation
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • informed written consent signed by legal representative (parent or guardian)
  • radical correction of congenital heart defect(s)
  • use of cardiopulmonary bypass
  • vasoactive-inotropic Score of 10 or greater during first 24 hours after surgery.

Exclusion Criteria

  • confirmed intranatal infection;
  • gestational age \< 37 weeks;
  • inotropic support prior to surgery;
  • acute renal or hepatic failure prior to surgery;
  • participation in conflicting randomised controlled studies.

Outcomes

Primary Outcomes

Major complications

Time Frame: Through study completion, an average of 30 days

Composite of all-cause mortality, extracorporal membrane oxygenation use, cardiac arrest, renal impairment (pRIFLE score of "injury" or higher), sepsis

Study Sites (1)

Loading locations...

Similar Trials